A total of 86 patients with ILD (mean age聽卤聽standard deviation, 42.6聽卤聽16.6 years; 60.5%female), who underwent BALF as part of their initial diagnostic work-up, were enrolled into 2 groups: sarcoidosis (n聽=聽41) and other ILD (n聽=聽45). Area under the receiver operating characteristic (ROC) curve (AUC) was used to describe the performance of CD103 for sarcoidosis diagnosis.
Sarcoidosis patients presented a significantly reduced CD103 expression in BALF T-lymphocytes, more pronounced in the CD4+ subset. The BALF CD103+CD4+/CD4+ ratio for a cutoff point of 0.45 was associated with a better diagnostic performance for sarcoidosis (AUC: 0.86 [95%confidence interval (95%CI): 0.78-0.94]; sensitivity: 81%; specificity: 78%), even for those with a CD4+/CD8+ ratio <3.5 (AUC: 0.79 [95%CI: 0.64-0.93]; sensitivity: 75%; specificity: 78%).
Assessment of CD103 expression in BALF CD4+ T-lymphocytes may be a reliable tool for sarcoidosis diagnosis, independently of CD4+/CD8+ ratio, pointing out the relevance of evaluating the CD103+CD4+/CD4+ ratio in the ILD diagnostic work-up.